| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Erratum to: Inhibition of mTOR in carcinoid tumors
|
Grozinsky-Glasberg, Simona
|
|
2012
|
7 |
3 |
p. 197
|
article
|
| 2 |
Inhibition of mTOR in carcinoid tumors
|
Grozinsky-Glasberg, Simona
|
|
2012
|
7 |
3 |
p. 189-195
|
article
|
| 3 |
New treatment options with cytotoxic agents in neuroendocrine tumours
|
Hammel, Pascal
|
|
2012
|
7 |
3 |
p. 169-172
|
article
|
| 4 |
Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors
|
Gaujoux, Sébastien
|
|
2012
|
7 |
3 |
p. 153-159
|
article
|
| 5 |
Profiling mTOR pathway in neuroendocrine tumors
|
Cingarlini, S.
|
|
2012
|
7 |
3 |
p. 183-188
|
article
|
| 6 |
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
|
Tijeras-Raballand, Annemilaï
|
|
2012
|
7 |
3 |
p. 173-181
|
article
|
| 7 |
Streptozocin-based chemotherapy is not history in neuroendocrine tumours
|
Weatherstone, Katie
|
|
2012
|
7 |
3 |
p. 161-168
|
article
|
| 8 |
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
|
Madrid, Andres Morales La
|
|
2012
|
7 |
3 |
p. 199-210
|
article
|
| 9 |
Targeting neuroendocrine tumor: mixing standard options with novel therapies
|
Raymond, Eric
|
|
2012
|
7 |
3 |
p. 151-152
|
article
|
Journal description